October 6, 2026 | 2-4 pm CT

Teleconference Only

Agenda

1. Welcome and Introductions
   1. Dr. Aparna Rajadhyaksha
2. Overview of Proposed LCD(s)
   2. MolDX: Transcriptional Biomarkers for Therapeutic Decision-Making in Renal Carcinoma (DL40435)
   3. MolDX: Next-Generation Sequencing for Hematologic Malignancies and Suspected Hematologic Malignancies (DL40427)
   4. MolDX: Genome-Wide Molecular Methodologies for the Detection of Copy Number Alterations and Structural Variants in Hematologic Neoplasms (DL40411)
3. Presentation of Oral Comments
4. Closing Remarks and Next Steps

Date Posted: August 27, 2026